In vitro antimicrobial susceptibility of clinical isolates from adult and paediatric patients in Jordan: Antimicrobial Testing Leadership and Surveillance (ATLAS) 2010-2021.

ABSTRACT:

Objectives

To evaluate the in vitro antimicrobial susceptibilities of Gram-positive and Gram-negative isolates from patients in Jordan between 2010 and 2021, through the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme.

Methods

Medical centres in Jordan collected bacterial isolates from hospitalised patients with defined infection sources between 2010 and 2021 (no isolates collected in 2014). Antimicrobial susceptibility was interpreted using CLSI standards. FDA-approved breakpoints were applied for tigecycline. The identification of β-lactamase genes was performed for a proportion of isolates using multiplex PCR assays.

Results

More than 92% of Acinetobacter baumannii collected were multidrug-resistant (MDR) and/or carbapenem-resistan

SUBMITTER: Al Jammal D 

PROVIDER: S-EPMC11732154 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature